Bio-Techne Target Price

Where could TECH trade next? Consensus target price: $63.

Get informed when a big investor buys or sells

+ Follow

Share Price

$72

Average Target Price

$63.11

12.3% downside

9 analysts in the last 4 months

High: $73 | Low: $49

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-26	StephensSteven Etoch	$73	1.4% upside
2026-06-26	Robert W. BairdCatherine Ramsey Schulte	$73	1.4% upside
2026-06-26	Deutsche BankJustin Bowers	$73	1.4% upside
2026-06-25	Leerink PartnersMarket Perform	$73	1.4% upside
2026-06-11	Piper Sandler	$65	9.7% downside
2026-05-14	RBC Capital	$62	13.9% downside
2026-05-07	Evercore ISIDaniel Markowitz	$50	30.6% downside
2026-05-07	Stifel Nicolaus	$50	30.6% downside
2026-05-07	Robert W. Baird	$49	31.9% downside
2026-02-05	Stifel Nicolaus	$65	9.7% downside
2026-02-05	UBS	$79	9.7% upside
2026-02-05	Robert W. Baird	$70	2.8% downside
2026-01-05	Evercore ISI	$62	13.9% downside
2025-12-12	Deutsche BankJustin Bowers	$72	0% upside
2025-11-20	Argus Research	$68	5.6% downside
2025-11-06	Evercore ISI	$68	5.6% downside
2025-09-02	RBC CapitalConor McNamara	$73	1.4% upside
2025-03-17	Evercore ISI	$75	4.2% upside
2024-10-31	Robert W. BairdCatherine Schulte	$84	16.7% upside
2024-10-30	KeyBancPaul Knight	$80	11.1% upside
2024-08-16	ScotiabankSung Ji Nam	$83	15.3% upside
2022-12-14	Deutsche Bank	$100	38.9% upside
2022-12-12	Citigroup	$100	38.9% upside
2022-12-07	RBC Capital	$89	23.6% upside
2022-12-05	Stephens	$105	45.8% upside
2022-05-05	KeyBancPaul Knight	$125	73.6% upside
2022-04-25	Wells Fargo	$92.5	28.5% upside
2021-05-06	CitigroupPatrick B Donnelly	$106.25	47.6% upside

Bio-Techne (TECH) FAQ

Bio-Techne (TECH) currently reports a target price of $63. Use the charts on this page to explore Bio-Techne's target price history and peer comparisons.

Analysts' average 12-month price target for Bio-Techne is $63, about 12.3% downside from the current share price of $72.0. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $63, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Techne, and consider following TECH for alerts when major investors trade the stock.

Bio-Techne is classified in the Healthcare sector. On target price, it currently shows $63. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TECH with unrelated industries.